SCHEMBL19743523

SCHEMBL19743523

NCCC(N)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5943563 0.77
SCHEMBL28385607 0.76
Hydrochloric Acid SCHEMBL22443016 0.74
SCHEMBL3423503 0.74 DNM1 (0.47)
SCHEMBL3420771 0.74
SCHEMBL19343250 0.72
SCHEMBL26531 0.72
SCHEMBL10964901 0.72
SCHEMBL7756760 0.70
Hydrochloric Acid SCHEMBL15635390 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3471707-A1 METHOD FOR THE PRODUCTION OF A DOSAGE FORM Omya International AG (CH) 2019-04-24 EP disclosed
WO-2017220498-A1 METHOD FOR THE PRODUCTION OF A DOSAGE FORM OMYA INTERNATIONAL AG (CH) 2017-12-28 WO disclosed
CN-107141293-A Nitrogen-containing heterocyclic compound, preparation method, intermediate, composition and application 上海医药集团股份有限公司 2017-09-08 CN disclosed
CN-103748098-B For treating or prevent the compound of respiratory syncytial virus disease 弗·哈夫曼-拉罗切有限公司 2016-06-29 CN disclosed
CN-102812005-B Beta-secretase inhibitors VITAE PHARMACEUTICALS INC 2014-12-10 CN disclosed
CN-101679408-A Bicyclic heterocyclic compounds as FGFR inhibitors ASTEX THERAPEUTICS LTD 2010-03-24 CN disclosed